A Lincoln-based biotechnology company has been given the 2017 Governor’s Bioscience Award.
Nature Technology Corp., which produces gene therapy products and DNA vaccines, was given the award at a ceremony Thursday night at the Strategic Air Command and Aerospace Museum near Ashland.
The award recognizes individuals and companies that have made significant contributions to the Nebraska bioscience industry.
“Companies like Nature Technology have a great vision to apply intricate biological and genetic processes in service to some of the best companies in the world. They have done this through determination, creative energy and brilliance in their field,” Lt. Gov. Mike Foley said in a news release.
Nature Technology CEO Clague Hodgson said he was pleased to receive the honor.
“Our story goes to show that even a small company can achieve big things," Hodgson said. "Our technologies are very complex, as are the health challenges we focus on with our research customers."
Nature Technology, which has eight employees, makes biologic drugs that can be used in treating genetic disorders, cancers, disease and immunological targets in both humans and animals.
The company manufactures products that are used by larger pharmaceutical firms in research, development and clinical trials of vaccines, therapies and technology platforms.
Hodgson said a recent success was the sale of an allergy treatment program, based on the company's technology, by Immunomic Therapeutics Inc., to Astellas Pharma in Japan for over $300 million.
“The field of genetic medicines has taken 30 years to get to where we are today,” Hodgson added. “And we still have a way to go before the first approved products appear on the shelf. What excites us is developing platform technologies that can be used for treating a diversity of diseases.”